Your session is about to expire
← Back to Search
Atezolizumab for Urinary Tract Cancer
Study Summary
This trial will study the safety of atezolizumab as treatment for people with locally advanced or metastatic cancer of the urinary tract. The trial will also study how well atezolizumab works and what biomarkers are associated with atezolizumab.
- Urinary Tract Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 3 trial • 1225 Patients • NCT02008227Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are needed for this research study?
"This study has already wrapped up recruitment and is no longer looking for patients. The listing was created on November 30th, 2016 but was updated as recently as August 25th, 2022. There are 29 other trials currently underway for urologic neoplasms and 357 clinical trials that involve Atezolizumab if you are seeking additional studies to participate in."
Have medical professionals done anything like this before?
"Atezolizumab has a long history, with the first study being conducted in 2008. The original sponsor of this research was Hoffmann-La Roche. After the initial trial involving 720 patients, Atezolizumab received approval for Phase 2 clinical trials. As of now, there are 357 ongoing studies taking place in 1665 cities and 74 countries."
Atezolizumab is most often given to patients for what reason?
"Atezolizumab is most commonly prescribed as a treatment for small cell lung cancer, however it has also been used to effectively treat other conditions such as non-small cell lung carcinoma and postoperative malignant neoplasms."
Can you provide a list of other times Atezolizumab has been tested in a clinical setting?
"Atezolizumab was first studied in 2008 and there have been 79 completed studies on the medication to date. There are currently 357 clinical trials underway, with a significant number of them taking place in Calgary, Alberta."
What are the most severe side effects associated with Atezolizumab?
"Atezolizumab's safety is estimated to be a 3. This rating comes from the fact that this is a Phase 3 trial, signifying that not only is there some evidence of efficacy, but also multiple rounds of data affirming its safety."
Are people still being recruited for this clinical trial?
"This particular clinical trial, which was created on November 30th 2016 and last updated on August 25th 2022, is not currently looking for patients. Although this study has completed recruitment, there are 386 other studies that participants can sign up for."
At how many distinct sites is this research being conducted?
"There are a total of 5 enrolling patients for this study, which includes Tom Baker Cancer Centre-Calgary in Calgary, Royal Victoria Hospital in Barrie, and Queen Elizabeth II Health Sciences Centre in Halifax. Additionally, there are 5 other locations where this trial is taking place."
Share this study with friends
Copy Link
Messenger